ABBOTT LABORATORIES (ABT) - Price, trends, fundamentals and chart - Passport to Wall Street

ABBOTT LABORATORIES (NYSE: ABT)

Overview

current price

$106.85

$106.85

change

1.58 | 1.50%

1.58 | 1.50%

Yesterday's Close

105.27

open

105.98

volume

3.75 M

30d. avg volume.

6.47 M

1 day

105.38 - 107.77

52 weeks

89.67 - 121.64

p/e

32.29

beta

0.7403

market cap

182.66 B

dividend yield

2.09%

Industry

-

News and Commentary

Market Update: S&P 500 Clinches Fresh All-Time High on Broader Tech Rally The S&P 500 rose slightly higher on Wednesday to post a new all-time closing high as a broader market tech rally helped push the index higher. The Dow Jones Industrial Average, h...

Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip In COVID-19 Testing Demand Abbott Laboratories (ABT

Abbott Stock Gains On Q3 Performance, 10% Organic Diagnostics Revenue Growth, Raised Annual Outlook Abbott Laboratories (ABT

Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To... Apple Inc (AAPL

Russia Is Seizing European Company Assets — What US Businesses Are Still At Risk? In recent months, Russia began seizing assets from companies based in Western countries.The most recent development came last week, when the Russian gov...

Market Update: Wall Street Fails to Extend Two-Day Rally, Dow Falls 100 Points Stocks fell lower on Wednesday as Wall Street struggled to extend its two-day rally from earlier in the week. The Dow Jones Industrial Average fell about 100 points, while the S&...

Abbott to Resume Production of Similac Baby Formula Following Nationwide Shortage On August 26, nutrition and health company Abbott

Market Update: Stocks Extend Gains, Netflix Q2 Subscriber Loss Better-Than-Feared Stocks rose on Wednesday as investors looked to extend gains from the previous session as more corporate earnings rolled in. The Nasdaq Composite jumped over 1.5%, while the Dow...

Coronavirus Stocks Possibly Topping The market environment has been markedly different since the middle of 2021 from what we experienced off the stock market bottom in March 2020.Many of t...

F.D.A. Authorizes Two COVID Diagnostics Tests for At-Home Use The U.S. Food and Drug Administration (F.D.A.) authorized a rapid coronavirus diagnostics test developed by Abbott Laboratories

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more